Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression

被引:169
作者
Michou, AI
Santoro, L
Christ, M
Julliard, V
Pavirani, A
Mehtali, M
机构
[1] TRANSGENE SA,F-67000 STRASBOURG,FRANCE
[2] ICGM,INSERM,U152,PARIS,FRANCE
关键词
adenovirus; factor IX; beta-galactosidase; moose; immune response;
D O I
10.1038/sj.gt.3300412
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
E1-deleted adenovirus (Ad) vectors expressing the human coagulation factor IX (hFIX) or the bacterial beta-galactosidase (lacZ) were injected intravenously into various strains of immunocompetent (C57Bl/6, BALB/c, CD1, CBA/J, C3H) and immunodeficient (BALB/c-nu/nu, C57Bl/6-nu/nu, SCID, NIH-bg-nu-xid) mice. Regular analysis of mouse sera and tissues showed a persistent expression of both transgenes in immunodeficient mice, while detection diminished very rapidly in immunocompetent mice. The mechanisms responsible for the transient detection of the two transgenes were however not identical. Rapid decline of lacZ expression was correlated with a rapid decrease of viral DNA sequences, and consequently to the induction of a cellular immune response to the lacZ antigen. In contrast, absence of detectable levels of serum hFIX in immunocompetent animals was not associated with a loss of viral DNA but was strictly correlated with the induction of anti-hFIX antibodies. Surprisingly, anti-hFIX antibodies were never detected in C57Bl/6 mice, leading to prolonged defection of hFIX. These results suggest that cellular immunity to viral antigens plays a minor role in the early extinction of transgene expression and illustrate the influence of the cellular (eg lacZ) or humoral (eg hFIX) immunity to transgene-encoded products on the persistence of transgene expression.
引用
收藏
页码:473 / 482
页数:10
相关论文
共 48 条
[1]   CLONING AND EXPRESSION OF THE MOUSE PGK-1 GENE AND THE NUCLEOTIDE-SEQUENCE OF ITS PROMOTER [J].
ADRA, CN ;
BOER, PH ;
MCBURNEY, MW .
GENE, 1987, 60 (01) :65-74
[2]  
ANDRIOLE GL, 1985, J IMMUNOL, V135, P5
[3]  
[Anonymous], 1990, VIROLOGY
[4]   CHARACTERIZATION OF 2 DIFFERENTLY PROCESSED FORMS OF HUMAN RECOMBINANT FACTOR-IX SYNTHESIZED IN CHO CELLS TRANSFORMED WITH A POLYCISTRONIC VECTOR [J].
BALLAND, A ;
FAURE, T ;
CARVALLO, D ;
CORDIER, P ;
ULRICH, P ;
FOURNET, B ;
DELASALLE, H ;
LECOCQ, JP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 172 (03) :565-572
[5]  
BARR D, 1995, GENE THER, V2, P151
[6]  
BERKNER KL, 1988, BIOTECHNIQUES, V6, P616
[7]   AN EFFICIENT AND FLEXIBLE SYSTEM FOR CONSTRUCTION OF ADENOVIRUS VECTORS WITH INSERTIONS OR DELETIONS IN EARLY REGION-1 AND REGION-3 [J].
BETT, AJ ;
HADDARA, W ;
PREVEC, L ;
GRAHAM, FL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8802-8806
[8]   A SEVERE COMBINED IMMUNODEFICIENCY MUTATION IN THE MOUSE [J].
BOSMA, GC ;
CUSTER, RP ;
BOSMA, MJ .
NATURE, 1983, 301 (5900) :527-530
[9]   Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli [J].
Chartier, C ;
Degryse, E ;
Gantzer, M ;
Dieterle, A ;
Pavirani, A ;
Mehtali, M .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4805-4810
[10]   IN-VIVO GENE DELIVERY AND EXPRESSION OF PHYSIOLOGICAL LEVELS OF FUNCTIONAL HUMAN FACTOR-VIII IN MICE [J].
CONNELLY, S ;
SMITH, TAG ;
DHIR, G ;
GARDNER, JM ;
MEHAFFEY, MG ;
ZARET, KS ;
MCCLELLAND, A ;
KALEKO, M .
HUMAN GENE THERAPY, 1995, 6 (02) :185-193